Global and China Drug Discovery Informatics Industry Ecological Development and Analysis Report 2023

Length- 109 Pages | Published Date - 2022-12-05 | Report Id- 4247
Single Licence $3100.00 | Enterprise License $5600.00 | Multiple Licensee $5600.00
This report aims to provide a comprehensive presentation of the global market for Drug Discovery Informatics, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery Informatics.

The Drug Discovery Informatics market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drug Discovery Informatics market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Discovery Informatics manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Drug Discovery Informatics market size in 2022 is 2682.66 million US dollars, and it is expected to be 4970.53 million US dollars by 2029, with a compound annual growth rate of 9.21% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Drug Discovery Informatics market include Novo Informatics, IO Informatics, Openeye Scientific Software, Collaborative Drug Discovery, and GVK Biosciences. The share of the top 3 players in the Drug Discovery Informatics market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Drug Discovery Informatics market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Sequencing and Target Data Analysis accounted for XX% of Drug Discovery Informatics market in 2022. Docking share of XX%.
Pharmaceutical and Biopharmaceutical Companies accounted for XX% of the Drug Discovery Informatics market in 2022. Contract Research Organizations (CROs) accounts for XX%.

Highlights-Regions

North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico

Player list
Novo Informatics
IO Informatics
Openeye Scientific Software
Collaborative Drug Discovery
GVK Biosciences
Certara
Selvita
Charles River Laboratories
Dassault Systèmes
Schrödinger
Perkinelmer
IBM
Jubilant Life Sciences and Laboratories
Thermo Fisher Scientific
Infosys
Eurofins Scientific
Albany Molecular Research Inc.
Accenture
Cognizant
Insilico Medicine
Boehringer Ingelheim International GmbH

Types list
Sequencing and Target Data Analysis
Docking
Molecular Modelling
Libraries & Database Preparation
Other Function (Screening and ADMET characterization)

Application list
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations (CROs)
Other End Users

Contact US Anytime

Contact US Anytime

Find More

Global and China Drug Discovery Informatics Industry Ecological Development and Analysis Report 2023

Get a FREE sample

Have Requests? Need Customization? Our Research Team Will Help to Maximize Your "Interest Scope and Content Customization" into Our Analysis Report.

Custom Research
Dongguan Jianpeng Intelligent Technology Co., Ltd
top
Copyright © 2020-2025 Arsta Research All Rights Reserved
Technical support : Cssl
Choose a different language

Sample Request

Message